Titulo:
Terapia antirretroviral en adultos infectados por VIH
.
Guardado en:
0121-7372
2462-991X
13
2004-12-01
172
183
Fundación Universitaria de Ciencias de la Salud FUCS - 0
info:eu-repo/semantics/openAccess
http://purl.org/coar/access_right/c_abf2
| id |
metarevistapublica_fucsalud_revistarepertoriodemedicinaycirugia_98_article_361 |
|---|---|
| record_format |
ojs |
| spelling |
Terapia antirretroviral en adultos infectados por VIH Díaz Granados, Carlos A. 13 4 Núm. 4 , Año 2004 : Octubre – Diciembre Artículo de revista Journal article 2004-12-01 00:00:00 2004-12-01 00:00:00 2004-12-01 application/pdf Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud Revista Repertorio de Medicina y Cirugía 0121-7372 2462-991X https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/361 10.31260/RepertMedCir.v13.n4.2004.361 https://doi.org/10.31260/RepertMedCir.v13.n4.2004.361 https://creativecommons.org/licenses/by-nc-sa/4.0/ Fundación Universitaria de Ciencias de la Salud FUCS - 0 172 183 UNAIDS/WHO. Colombia: Epidemiological fact sheet on HIV/AIDS and sexually transmitted diseases. (Citado 2002). Disponible en: PDF htpp://www.who.int/emchiv/fact sheets/pdfs/Colombia. «Terapia antirretroviral». Disponible en PDF. http://aidsinfo.nih.gov/quidelines/adult/AA 032304. «Terapia antirretroviral».Disponible en PDF. http://www.who.int/hiv/pub/prev care/en/arvrevisionsp. Egger M, May M, Chene et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 2002;360(9340):1178 Florence E, Lundgren J, Dreezen C, et al. Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study. HIV Medicine 2003;4(3):255-62. Ahdieh-Grant L, Yamashita TE, Phair JP, et al. When to Initiate Highly Active Antiretroviral Therapy: A Cohort Approach. Am J Epidemiol 2003;157:738-46. Albrecht MA, Bosch RJ, Hammer SM, et al. Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection. N Engl J Med. 2001;345(6):398-407. Staszewski S, Morales-Ramirez J, Tashima KT, et al. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team. N Engl J Med. 1999;341(25):1865-73. Gulick RM, Ribaudo HJ, Shikuma CM, et al. ACTG 5095: A comparative study of 3 protease inhibitor-sparing antiretroviral regimens for the initial treatment offlIV infection. In: International AIDS Society Abstracts of the 2 nd Conference on HIV Pathogenesis and Treatment; 2003 Jul 13-16; París Francia. París 1992.Abstractno.41 Cozzi-Lepri A, Phillips AN,D'Arminio Monforte A, et al. Virologic and immunologic response to regimens containing nevirapine or efavirenz in combination with 2 nucleoside analogues in the Italian Cohort Naive Antiretrovirals study. J Infect Dis 2002; 185:1062-69. P Keiser, N Nassar, C White, G Koen, Moreno S. Comparison of nevirapine- and efavirenz-containing antiretroviral regimens in antiretroviral-naive patients: a cohort study. HIV Clin Trials 2002; 3:296-303. Van Leth F, Phanuphak P, Ruxrugtham K, et al. Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomized open-label trial, the 2NN Study. Lancet 2004;363: 1253-63. Walmsley S, Bernstein B, King M, et al. Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection. N Engl J Med 2002;346(26):2039-46. Sustiva. Package insert. T4-B0001A-10-03. Princenton, NJ, Bristol-Myers Squibb Company: 2003. A phase III study comparing the antiviral efficacy and safety of BMS-232632 (ATV) with efavirenz (EFV), each in combination with fixed doce zidovudine-lamivudine (ZDV+3TC).Princeton, NJ Bristol-Myers Squibb Company. ACTG 384. XIV International AIDS Conference, Barcelona 2002, Abstracts LB20a and LB20b. Boubaker K, Flepp M, Sudre P, et al. Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study. Clin Infect Dis 2001; 33(11):1931-7. New nevirapine label underscores the risk for hepatotoxicity in key populations. AIDS Clinical Care 2004;16(3):2. Maggiolo F, Migliorino M, Pirali A, Pravettoni G, Caprioli S, Suter F. Duration of viral suppression in patients on stable therapy for HIV-1 infection is predicted by plasma HIV RNA level after 1 month of treatment. J Acquir Immune Defic Syndr 2000;25(1):36-43. Raboud JM, Rae S, Montaner JS. Predicting HIV RNA virologic outcome at 52-weeks follow-up in antiretroviral clinical trials. The INCAS and AVANTI Study Groups. J Acquir Immune Defic Syndr 2000;24(5):433-9. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21-30. https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/361/387 info:eu-repo/semantics/article http://purl.org/coar/resource_type/c_6501 http://purl.org/coar/resource_type/c_dcae04bc http://purl.org/redcol/resource_type/ARTREV info:eu-repo/semantics/publishedVersion http://purl.org/coar/version/c_970fb48d4fbd8a85 info:eu-repo/semantics/openAccess http://purl.org/coar/access_right/c_abf2 Text Publication |
| institution |
FUNDACIÓN UNIVERSITARIA DE CIENCIA DE LA SALUD |
| thumbnail |
https://nuevo.metarevistas.org/FUNDACIONUNIVERSITARIADECIENCIADELASALUD/logo.png |
| country_str |
Colombia |
| collection |
Revista Repertorio de Medicina y Cirugía |
| title |
Terapia antirretroviral en adultos infectados por VIH |
| spellingShingle |
Terapia antirretroviral en adultos infectados por VIH Díaz Granados, Carlos A. |
| title_short |
Terapia antirretroviral en adultos infectados por VIH |
| title_full |
Terapia antirretroviral en adultos infectados por VIH |
| title_fullStr |
Terapia antirretroviral en adultos infectados por VIH |
| title_full_unstemmed |
Terapia antirretroviral en adultos infectados por VIH |
| title_sort |
terapia antirretroviral en adultos infectados por vih |
| author |
Díaz Granados, Carlos A. |
| author_facet |
Díaz Granados, Carlos A. |
| citationvolume |
13 |
| citationissue |
4 |
| citationedition |
Núm. 4 , Año 2004 : Octubre – Diciembre |
| publisher |
Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud |
| ispartofjournal |
Revista Repertorio de Medicina y Cirugía |
| source |
https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/361 |
| language |
|
| format |
Article |
| rights |
https://creativecommons.org/licenses/by-nc-sa/4.0/ Fundación Universitaria de Ciencias de la Salud FUCS - 0 info:eu-repo/semantics/openAccess http://purl.org/coar/access_right/c_abf2 |
| type_driver |
info:eu-repo/semantics/article |
| type_coar |
http://purl.org/coar/resource_type/c_6501 |
| type_version |
info:eu-repo/semantics/publishedVersion |
| type_coarversion |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| type_content |
Text |
| publishDate |
2004-12-01 |
| date_accessioned |
2004-12-01 00:00:00 |
| date_available |
2004-12-01 00:00:00 |
| url |
https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/361 |
| url_doi |
https://doi.org/10.31260/RepertMedCir.v13.n4.2004.361 |
| issn |
0121-7372 |
| eissn |
2462-991X |
| doi |
10.31260/RepertMedCir.v13.n4.2004.361 |
| citationstartpage |
172 |
| citationendpage |
183 |
| url2_str_mv |
https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/361/387 |
| _version_ |
1811201492355383296 |